Apex Legends remains one of the most popular first-person shooters year after year, and its esports scene continues to grow ...
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and ...
The inaugural ALGS Open is set to begin at the Ernest N. Morial Convention Center from May 1-4, 2025, marking what is ...
Aligos Therapeutics (ALGS) announced positive data from three oral presentations at the 34th Annual Meeting of the Asian Pacific Association ...
The ALGS Open will take place in New Orleans, LA from May 1-4, with a massive 160 Apex teams participating in the first ...
Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie ...
Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the ...
Upgrade your Yahoo Finance plan to get complete details for Aligos Therapeutics, Inc. Get advanced tools and insights to navigate the markets.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results